1–3 of 3 results for therapeutics
Assessment of Central Subfield Thickness Fluctuations and Impact on Vision in Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS)
Chirag D. Jhaveri, MD, FASRS
Annual Meeting Talks
2021
New Therapeutics for Uveitis and Best Uveitis Cases
Sunil Srivastava, MD
Updates from the Field
2017
Future DME Therapeutics